Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

LifeMD (LFMDP) Accumulated Expenses (2019 - 2025)

Historic Accumulated Expenses for LifeMD (LFMDP) over the last 7 years, with Q3 2025 value amounting to $22.1 million.

  • LifeMD's Accumulated Expenses rose 507.6% to $22.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $22.1 million, marking a year-over-year increase of 507.6%. This contributed to the annual value of $22.8 million for FY2024, which is 6367.19% up from last year.
  • According to the latest figures from Q3 2025, LifeMD's Accumulated Expenses is $22.1 million, which was up 507.6% from $14.9 million recorded in Q2 2025.
  • In the past 5 years, LifeMD's Accumulated Expenses ranged from a high of $22.8 million in Q4 2024 and a low of $3.4 million during Q2 2021
  • In the last 5 years, LifeMD's Accumulated Expenses had a median value of $14.2 million in 2023 and averaged $13.9 million.
  • As far as peak fluctuations go, LifeMD's Accumulated Expenses soared by 479191.73% in 2021, and later decreased by 6.95% in 2024.
  • Quarter analysis of 5 years shows LifeMD's Accumulated Expenses stood at $11.6 million in 2021, then grew by 4.92% to $12.2 million in 2022, then rose by 14.56% to $13.9 million in 2023, then soared by 63.67% to $22.8 million in 2024, then decreased by 3.21% to $22.1 million in 2025.
  • Its Accumulated Expenses stands at $22.1 million for Q3 2025, versus $14.9 million for Q2 2025 and $18.5 million for Q1 2025.